Legend Biotech Corp (LEGN) — Cash Flow Quality Index

Latest as of December 2024: -2.03x

Legend Biotech Corp (LEGN) has a Cash Flow Quality Index of -2.03x as of December 2024. Operating cash flow of $-82.08 Million is below net income of $40.51 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Legend Biotech Corp generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-2.03x
Operating CF / Net Income

Operating Cash Flow

$-82.08 Million
USD

Net Income

$40.51 Million
USD

Data as of

Dec 2024
Most recent filing

Legend Biotech Corp Cash Flow Quality Index (2017–2017)

Historical Cash Flow Quality Index for Legend Biotech Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LEGN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Legend Biotech Corp (2017–2017)

Year-by-year earnings quality comparison for Legend Biotech Corp. For live market cap and the full company financial profile, see LEGN market cap.

Year Quality Index Operating CF (USD) Net Income YoY Change
2017 -0.25x $-2.38 Million $9.37 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.